HTDK
- Company typePrivate
- Founded1996
- HeadquartersShanghai, China
- Headcount11–50
- GTM typeB2B
- OfferingServices
HTDK firmographics
Firmographics- Name
- HTDK
- Legal name
- HTDK (Shanghai) Co., Ltd.
- Website
- https://htdkgroup.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Where HTDK is headquartered
LocationHeadquarters
- HQ city
- Shanghai
- HQ country
- China
- HQ region
- Asia
Offices5 records
Markets served
HTDK business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Commercial Solutions Services: HTDK generates revenue by providing comprehensive end-to-end commercialization services for global high-value medical device brands entering the Chinese market. Services include clinical evaluation and product registration (NMPA), import/export management, warehousing and fulfillment, commercial channel management, inventory management, after-sales service, and post-market surveillance. Revenue is derived from service fees for these specialized commercial solutions.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels5 records
HTDK product offering
Product offeringCore offering
HTDK provides end-to-end commercialization solutions for global high-value medical device brands seeking to enter or expand in the Chinese market. Services span NMPA regulatory registration and clinical evaluation, import/export and customs management, bonded and temperature-controlled warehousing, nationwide distribution across 23 provinces, consignment inventory management, localized manufacturing, and post-market surveillance. The company also distributes a portfolio of partner-brand and proprietary medical devices across ophthalmology, medical aesthetics, dentistry, IVD, orthopedics, respiratory, cardiovascular/neurology, and surgical specialties.
Product overview
HTDK (华瑭医疗) operates as a comprehensive commercialization solutions platform for global high-value medical device brands entering and expanding in the Chinese market. The company offers end-to-end commercial solutions spanning clinical evaluation and product registration, import/export management, localized manufacturing, commercial distribution platforms, clinical education, supply chain management, inventory management, and post-market surveillance services. HTDK's product portfolio includes managed brands such as Sofwave™ for aesthetic medicine, Zimmer Biomet for musculoskeletal solutions, EVO ICL for ophthalmic refractive correction, PulmOne MiniBox+ for AI-powered pulmonary function testing, FAROMED for endoscopic defogging systems, and C.DIFF QUIK CHEK COMPLETE for diagnostic testing. The company also launched its proprietary 'Ginching' brand for localized endoscopic solutions. These products serve eight medical specialty segments: ophthalmology, medical cosmetology, stomatology, in vitro diagnostics, orthopedics, respiratory, cardiovascular/neurology, and surgical/minimally invasive surgery.
Differentiator
Problem solved
Functional benefit
Brands
- Ginching (暻清): HTDK's proprietary self-owned brand for endoscopic defogging systems, featuring German heritage technology with local optimization for Chinese hospitals.
Products and services
- Sofwave™素芙波 FDA-approved non-invasive dermatological aesthetic treatment device using 3D ultrasound technology to improve facial lines and wrinkles for subjects aged 22 and older; distributed in China for medical aesthetic clinics.
- 捷迈邦美 (Zimmer Biomet) Musculoskeletal solutions including orthopedic implants, joint reconstruction and replacement products; distributed in China for hospitals and surgical centers.
- EVO ICL (Implantable Collamer® Lens) STAAR Surgical's phakic implantable Collamer lens for myopia and astigmatism correction, providing an alternative to laser eye surgery; distributed to ophthalmic hospital chains across China.
- 肺功能仪 (PulmOne MiniBox+) Cabin-less, AI-powered portable pulmonary function testing device offering Spirometry, Total Lung Capacity (TLC), Diffusing Capacity (DLCO), and Bronchodilator Challenges in a compact desktop format; for hospitals and respiratory departments.
- 手术内窥镜加热器除雾系统 (FAROMED Endoscopic Defogging System) Surgical endoscope heater defogging system with rapid defogging capability and up to 14 days standby battery life, designed for 4K Ultra-HD, fluorescence endoscopy, 3D endoscopy, and Da Vinci robotic surgical systems.
- 艰难梭菌谷氨酸脱氢酶抗原及毒素检测试剂盒 (C.DIFF QUIK CHEK COMPLETE) Rapid membrane enzyme immunoassay for simultaneous detection of Clostridium difficile glutamate dehydrogenase antigen and toxins A and B in a single reaction well; for hospital laboratories.
- Ginching (旸清) Endoscopic Defogging System HTDK's proprietary self-owned brand for endoscopic defogging systems, featuring German heritage heating and defogging technology with localization for Chinese hospitals; achieves ultra-fast defogging within 10 seconds with automatic temperature control.
- Clinical Evaluation and NMPA Product Registration Customized services covering NMPA registration, clinical trials, and real-world data research for global medical device brands seeking China market entry.
- Import/Export Management Data-driven technology stack ensuring visibility across EDI, air freight, and ocean freight for cross-border medical device movement into China.
- Localized Manufacturing Innovative localized manufacturing strategies and execution plans for global medical device brands seeking China production.
- Commercial Platform / Nationwide Distribution Strong nationwide distribution network with flexible and customized cooperation models to meet the unique needs of global medical device brands across China.
- Clinical Academic Education Programs to accelerate clinician adoption of innovative medical devices, including product training, patient education, and online training modules.
- Supply Chain Management and Warehousing Compliant, reliable, secure and cost-effective supply chain management with bonded and temperature-controlled warehousing facilities across China.
- Inventory Management (Consignment Services) Digital-enabled inventory management ensuring accuracy, timely supply, and smooth sales channel operations, including consignment services for ophthalmic products such as IOLs.
- Post-Market Surveillance Comprehensive post-market quality tracking covering product returns, recalls, and on-site corrective actions for distributed medical devices.
Quantifiable outcome
- HTDK operates over 24,000 sqm of bonded warehousing in Shanghai Waigaoqiao Free Trade Zone
- +2 more outcomes
Companies that use HTDK
Customer profileNamed customers10 records
Segments9 records
Ideal customer profiles1 record
HTDK technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature5 records
HTDK partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered flagship, minor and core.
- Alcon ChinaflagshipHTDK has partnered with Alcon since 2006, operating as one of Alcon China's most trusted long-term business partners. HTDK manages Alcon China's Kunshan Logistics Center, providing comprehensive warehousing and distribution services. The partnership covers Beijing-Tianjin-Hebei region and Yangtze River Delta strategic areas. Alcon (founded 1945, headquartered in Geneva) is a global leader in eye care serving over 140 countries.
- Goodman GroupminorGoodman Group provided the real estate facilities for HTDK's Kunshan Logistics Center, partnering to customize and upgrade storage units meeting Alcon's high standards for warehousing, environmental controls, and sustainability.
- Sofwave Medical LtdcoreHTDK signed an exclusive strategic cooperation agreement with Sofwave Medical Ltd for mainland China market. HTDK provides end-to-end commercialization services including NMPA registration support and nationwide distribution for Sofwave's energy-based non-invasive medical beauty devices. HTDK showcased Sofwave products at CIIE innovation incubation zone.
- STAAR SurgicalcoreHTDK serves as STAAR Surgical's commercialization services partner in China for EVO+ ICL (V5) implantable Collamer lens. HTDK provides end-to-end commercial support including regulatory-compliant distribution, import/export, inventory management, after-sales service, and nationwide supply-chain operations across leading ophthalmic groups.
- PulmOne (Israel)coreHTDK represents PulmOne MiniBox+ pulmonary function testing device in China market. This compact, desktop-sized pulmonary function testing system uses AI algorithms and is featured at the 2026 China Medical Equipment Conference.
- FAROMED (Germany)coreHTDK distributes FAROMED endoscopic defogging system in China. The German-made surgical endoscope heater defogging system is designed for 4K Ultra-HD, fluorescence endoscopy, 3D endoscopy, and Da Vinci robotic surgical systems. HTDK is also pursuing localization of this product.
- Zimmer BiometcoreHTDK distributes Zimmer Biomet musculoskeletal solutions including orthopedic implants and joint replacement devices in China.
- TECHLABcoreHTDK distributes TECHLAB C.DIFF QUIK CHEK COMPLETE rapid membrane enzyme immunoassay for detecting Clostridium difficile glutamate dehydrogenase antigen and toxins A and B.
- BreasminorHTDK distributes Breas respiratory care products as part of its respiratory segment offerings.
- International Chamber of CommerceminorEcosystem partnership for international trade facilitation and healthcare industry collaboration.
- Medical Device Industry AssociationminorEcosystem partnership supporting medical device industry standards and advocacy.
- Boao Hope CityminorPartnership for healthcare innovation and development initiatives.
- United Family HealthminorPartnership for private healthcare services distribution.
Scale indicators7 records
Recent moves9 records
Expansion highlights2 records
HTDK competitors and assessment
Company assessmentDirect peers
- DKSH: HTDK originated as DKSH's China healthcare business before the 2018 Warburg Pincus buyout. DKSH remains the global benchmark for Market Expansion Services in Asia, providing identical commercial-solutions infrastructure (regulatory, importation, distribution, after-sales) for consumer goods, healthcare, and industrial clients.
Broad incumbents
- Owens & Minor: Global medical device and supply-chain solutions provider with distribution, kitting, and logistics services comparable in function to HTDK's bonded warehousing, distribution, and after-sales offering, though serving Western hospital systems rather than China market entry.
- China Resources Pharmaceutical Group: State-backed pharmaceutical and medical device distribution arm of China Resources Holdings with nationwide reach, including medical device channels and cold-chain capability that increasingly compete with specialty CSOs like HTDK.
- Cardinal Health (International Medical Products): Global medical products distributor whose medical segment provides wholesale, distribution, and supply-chain services to healthcare providers worldwide; overlap with HTDK in the medical device supply-chain and channel services category at international scale.
- Sinopharm Group: China's largest state-owned pharmaceutical and medical device distributor with nationwide hospital network, cold-chain logistics, and bonded warehouses. Overlaps with HTDK on medical device distribution but at far larger scale across all therapeutic categories and geographies.
- Shanghai Pharmaceuticals Holding: Major state-controlled pharmaceutical and medical device distributor in China with extensive distribution infrastructure and hospital relationships, serving as a comparable wholesale and channel-management platform though with a broader pharmaceutical focus.
Others
- DHL Supply Chain (Life Sciences & Healthcare): Global 3PL providing GDP-compliant warehousing, temperature-controlled storage, and distribution for medical device and pharma manufacturers, overlapping with HTDK's bonded, cold-chain, and customs-clearance services as an upstream logistics enabler rather than direct sales-channel competitor.
Regional players
- Zuellig Pharma: Asia-headquartered healthcare distribution specialist (similar Market Expansion Services-like model) that provides commercialization, regulatory, warehousing, and distribution for multinational pharma and medical device clients across APAC, a directly comparable service platform outside mainland China.
- Medipal Holdings: Japan's largest medical device and pharmaceutical wholesaler, with deep hospital-channel relationships and the ability to manage end-to-end commercialization for international manufacturers, comparable in role to HTDK but concentrated in the Japanese market.
Emerging players
- JoinTown Pharmaceutical Group: China-based pharmaceutical and medical device distribution group expanding into cold-chain and specialty medical device channels, increasingly competing for Western brand commercialization mandates similar to HTDK's specialty focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
HTDK social profiles
Digital presenceHTDK compliance and trust
Trust signalCompliance16 records
HTDK financial estimates
Financial estimateRevenue estimate
Valuation estimate
HTDK leadership team
Management profileNumber of profiles
Profiles5 records
HTDK subsidiaries and ownership
Company hierarchySubsidiaries1 record
HTDK funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HTDK M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HTDK
What does HTDK do?
HTDK provides end-to-end commercialization solutions for global high-value medical device brands seeking to enter or expand in the Chinese market. Services span NMPA regulatory registration and clinical evaluation, import/export and customs management, bonded and temperature-controlled warehousing, nationwide distribution across 23 provinces, consignment inventory management, localized manufacturing, and post-market surveillance. The company also distributes a portfolio of partner-brand and proprietary medical devices across ophthalmology, medical aesthetics, dentistry, IVD, orthopedics, respiratory, cardiovascular/neurology, and surgical specialties.
Is HTDK a public or private company?
HTDK is a private company. It is classified as private equity controlled and is currently operating.
When was HTDK founded?
HTDK was founded in 1996. It employs 11 to 50 people.
Where is HTDK based?
HTDK is headquartered in Shanghai, China, in the Asia region.
How does HTDK make money?
One revenue line is on record: commercial Solutions Services.
Who are HTDK's main competitors?
DKSH is listed as a direct peer. Broad incumbents are Owens & Minor, China Resources Pharmaceutical Group, Cardinal Health (International Medical Products), Sinopharm Group and Shanghai Pharmaceuticals Holding. DHL Supply Chain (Life Sciences & Healthcare) is listed as an others. Regional players are Zuellig Pharma and Medipal Holdings. JoinTown Pharmaceutical Group is listed as an emerging player.
Does HTDK have an API?
No public API is recorded for HTDK.